Abstract

BACKGROUND CONTEXT: Recently, a FDA sponsored prospective randomized clinical trial (RCT) evaluated patients treated with single level cervical artificial disc replacement (ADR) versus anterior diskectomy and fusion. The ADR group demonstrated superior outcomes with maintained cervical motion and the absence of adjacent cervical degeneration at two year follow-up. Data has not been reported on patients receiving ADR adjacent to fusion constructs or for patients who have greater than one level disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.